Signifier Medical Technologies has launched a new hardware remote control for its eXciteOSA sleep apnea therapy, aligning with CMS requirements to facilitate Medicare and Medicaid reimbursement and expanding patient access to treatment.
Signifier Medical Technologies reveals clinical trial outcomes in adherence and treatment efficacy for mild obstructive sleep apnea with its daytime therapy eXciteOSA.
This is the first device used while awake that is intended to improve tongue muscle function, which can help prevent the tongue from collapsing backwards.
A flow chart from Sleep 360 Sleep Diagnostic Center illustrates the OSA patient journey from referral to customized therapy.
Read More
Proceeds of the financing will be directed towards commercialization of eXciteOSA in core target markets, continued development of proprietary digital patient and physician interface platforms, the generation of additional clinical data to reinforce the therapeutic efficacy of eXciteOSA, and progressing reimbursement.
Read More
Many patients give up on CPAP because they can’t tolerate the machine. Implanted neurostimulators may help, but, like positive airway pressure, these new devices can take some getting used to.
Read More
The GOOD DESIGN award is presented by The Chicago Athenaeum Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies.
Read MoreProceeds will allow Signifier to invest further in its solutions for patients with sleep-disordered breathing conditions.
Read More“He brings a valuable combination of skills and experience that we believe will benefit Signifier not only in the near-term, as we continue the global commercialization of eXciteOSA and Snoozeal, but also in the future as we seek to build a global innovation-led healthcare company.”
Read More